Latest News

Stay up to date on the latest developments at Oncurious. Be sure to check in regularly for updates and press releases on ongoing research and clinical trials or just subscribe to our mailing list to receive regular updates.

 

 

  • 1 Sep 2017
    ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB
  • 17 Jan 2017
    ONCURIOUS NV Announces European Commission Confirmed Orphan Medicinal Product Designation for TB-403 for Medulloblastoma